News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,755 Results
Type
Article (42390)
Company Profile (414)
Press Release (661951)
Section
Business (212156)
Career Advice (2039)
Deals (36521)
Drug Delivery (85)
Drug Development (83612)
Employer Resources (170)
FDA (16398)
Job Trends (15328)
News (356761)
Policy (33425)
Tag
Academia (2703)
Africa (762)
Alliances (52622)
Alzheimer's disease (1197)
Approvals (16339)
Arizona (181)
Artificial intelligence (71)
Asia (39259)
Australia (6474)
Bankruptcy (360)
Best Places to Work (11644)
Biosimilars (62)
Biotechnology (306)
C2C Services and Suppliers (81196)
California (1595)
Canada (839)
Cancer (339)
Career advice (1694)
Cell therapy (112)
China (111)
Clinical research (65056)
Collaboration (120)
Colorado (66)
Connecticut (62)
COVID-19 (2576)
Cystic fibrosis (76)
Data (127)
Diabetes (66)
Diagnostics (6116)
Drug pricing (68)
Earnings (85335)
Employer resources (143)
Europe (86094)
Events (112777)
Executive appointments (90)
FDA (16566)
Florida (211)
Funding (98)
Gene therapy (84)
GLP-1 (538)
Government (4464)
Healthcare (19340)
Hotbed/Location (494308)
Idaho (61)
Illinois (251)
Indiana (136)
Infectious disease (2600)
Inflammatory bowel disease (94)
Interviews (317)
IPO (16604)
Job creations (3761)
Job search strategy (1455)
Kansas (96)
Layoffs (420)
Legal (8019)
Lung cancer (73)
Manufacturing (75)
Maryland (353)
Massachusetts (1377)
Medical device (13389)
Medtech (13392)
Mergers & acquisitions (19713)
Metabolic disorders (227)
Michigan (114)
Minnesota (213)
Neuroscience (1314)
New Jersey (485)
New York (493)
NextGen Class of 2024 (6954)
Non-profit (4698)
North Carolina (628)
Northern California (705)
Obesity (140)
Ohio (98)
Opinion (196)
Patents (60)
Pennsylvania (518)
People (58085)
Pharmaceutical (82)
Phase I (20338)
Phase II (28701)
Phase III (21308)
Pipeline (92)
Postmarket research (2588)
Preclinical (8713)
Press Release (70)
Rare diseases (121)
Real estate (6161)
Recruiting (64)
Regulatory (21824)
Research institute (2467)
Resumes & cover letters (356)
South America (1130)
Southern California (638)
Startups (3859)
Texas (191)
United States (7671)
Vaccines (481)
Washington State (243)
Weight loss (126)
Date
Last 7 days (478)
Last 30 days (2236)
Last 365 days (38998)
2024 (25524)
2023 (41480)
2022 (52778)
2021 (57301)
2020 (55765)
2019 (48633)
2018 (36677)
2017 (33663)
2016 (33086)
2015 (39208)
2014 (32824)
2013 (27727)
2012 (29749)
2011 (30431)
2010 (28470)
704,755 Results for "partner therapeutics inc ptx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
Pharm Country
VYNE Therapeutics to Participate in Leerink Partners Therapeutics ForumBoston event to focus on Immunology & Inflammation (I&I) and Metabolic Diseases
VYNE Therapeutics Inc. today announced members of VYNE’s management will participate in one-on-one meetings at the Leerink Partners Therapeutics Forum on Immunology and Inflammation and Metabolic Diseases on Tuesday, July 9, 2024.
June 26, 2024
·
1 min read
Genetown
Partner Therapeutics Announces Publication of 30-month Randomized Open Label Study of LEUKINE® in Combination with Whole Lung Lavage for Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Partner Therapeutics, Inc. (PTx) announced today that the European Respiratory Journal published the results of a prospective, randomized clinical trial of Leukine.
November 30, 2023
·
7 min read
Lone Star Bio
Nanoscope Therapeutics to Participate in the 2024 Leerink Partners Biopharma Private Company Connect
Nanoscope Therapeutics Inc. today announced that management will participate in one-on-one meetings with investors at the 2024 Leerink Partners Biopharma Private Company Connect, being held virtually on June 25-26, 2024.
June 18, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
3 min read
·
Voyager Therapeutics, Inc.
Policy
Partner Therapeutics’ Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Partner Therapeutics, Inc. announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device Agency for the inhaled use of Leukine, branded in Japan as Sargmalin, to treat aPAP.
April 3, 2024
·
8 min read
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Cadrenal Therapeutics, Inc. will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.
May 23, 2024
·
2 min read
BioMidwest
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
Axogen, Inc. will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference in Austin, TX, on Wednesday, May 29, 2024, at 3:40 p.m. CT / 4:40 p.m. ET.
May 14, 2024
·
3 min read
Biotech Beach
Autobahn Therapeutics to Participate in the Leerink Partners Biopharma Private Company Connect
Autobahn Therapeutics today announced that Kevin Finney, President and Chief Executive Officer, will participate in the Leerink Partners Biopharma Private Company Connect on Wednesday, June 26, 2024.
June 20, 2024
·
1 min read
1 of 70,476
Next
